Me Today Limited

Me Today Limited

NNZX:MEE
0.08
NZD
+0.00
(-1.22%)
-0.41EPS
3.89MMarket Cap
Me Today Limited
NZX:MEE
(New Zealand Exchange)

Recent

price

0.08

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2023
2024
2025
NZD
-0.07
-0.09
0.54
0.83
-0.3
0.25
-0.47
0.1
0.09
-0.14
-0.04
1.33
0.17
- -
0.16
- -
Revenue per Share
-0.82
-1.22
-0.01
0.48
-0.69
-0.39
-1.7
-1.07
-1.19
-0.55
-0.87
-11.68
-0.41
- -
-0.41
- -
Basic EPS, GAAP
-0.76
-1.04
-0.57
-0.31
-0.25
-1.46
-1.65
-0.74
-0.41
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
0.49
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
7.63
6.37
7.1
6.56
5.52
4.91
3.57
2.28
1.98
1.4
0.68
0.82
- -
0.07
- -
Book Value per Share
- -
7.63
6.37
7.1
6.56
5.52
4.9
3.57
2.28
1.98
1.4
0.67
0.81
- -
0.06
- -
Tangible Book Value per Share
4
3
1
1
1
1
1
1
1
1
1
- -
7
17
27
61
Basic Weighted Avg Shares
- -
- -
1
1
- -
- -
-1
- -
- -
- -
- -
1
1
- -
4
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
1
- -
Depreciation Expense
-3
-3
- -
1
-1
-1
-2
-2
-2
-1
-1
-5
-3
- -
-11
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
1,173.02
1,298.37
-0.93
58.19
230.59
-155.76
364.92
-1,031.13
-1,367.39
404.48
1,998.41
-878.66
-235.2
- -
-260.18
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
14
- -
LT Debt
- -
11
9
10
9
8
7
5
3
3
2
4
6
- -
4
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
-0.07
7.17
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-0.07
7.17
-10.15
-6.53
-32.64
-25.17
-40.61
-25.95
-51.38
-156.84
-56
- -
- -
- -
Return on Common Equity (%)

Capital Structure

NZD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

NZD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

NZD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
4
2025
- -
- -
- -

Semi-annual Earnings Per Share

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
-0.41
2025
- -
- -
- -

Semi-annual Dividends Per Share

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Business
Me Today Limited Me Today Limited (NZX: MEE.NZ), founded in 2007 and headquartered in Auckland, New Zealand, produces, sells, and markets premium health and wellbeing products, including supplements for general health, relaxation, sleep support, stress care, muscle relaxation, immune function, joint comfort, brain focus, energy production, urinary tract health, hair, skin, and nail health; skincare products such as cream cleansers, moisturizers, serums, eye creams, and night creams; and manuka honey under its own brand, while also acting as an agent for third-party health suppliers. The company operates in New Zealand as its core market, with international expansion into the United States, Europe, China, Japan, the UAE, and Ireland through strategic partnerships, including an ongoing collaboration with Nutrition Family Company in China that achieved revenue targets in fiscal year 2025 and triggered a 20% ownership stake in the Me Today China trademark. In recent developments, Me Today completed a $2.2 million non-renounceable rights issue in October 2025, exceeding expectations with subscriptions from major shareholders Baker Investment Trust and Sinclair Investment Trust to fund brand investment, international sales growth, research, new product development—including 10 launches in fiscal 2025 and seven more in October 2025—and working capital; it also issued Series 1 and Series 2 warrants exercisable at 6 cents per share in 2026 and 2027, respectively, ring-fenced its King Honey operations in early 2024 following their liquidation in July 2025 with no ongoing financial obligations, and shifted manuka honey sourcing to more cost-effective contract packers.